Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study

BACKGROUND: One-year S-1 or six-month capecitabine/oxaliplatin (CAPOX) has been the standard adjuvant chemotherapy for gastric cancer (GC). We investigated outcomes according to the cycles of adjuvant chemotherapy, using data from the Korean Health Insurance and Assessment Service. METHODS: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae-Hwan, Ahn, Mi Sun, Choi, Yong Won, Kang, Seok Yun, Choi, Jin-Hyuk, Lee, Hyun Woo, Park, Minae, Kim, Hasung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440578/
https://www.ncbi.nlm.nih.gov/pubmed/36057562
http://dx.doi.org/10.1186/s12885-022-10006-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440578/
https://www.ncbi.nlm.nih.gov/pubmed/36057562
http://dx.doi.org/10.1186/s12885-022-10006-7

Ejemplares similares